Details for Patent: 6,020,311
✉ Email this page to a colleague
Summary for Patent: 6,020,311
Title: | GRF analogs with increased biological potency |
Abstract: | The present invention relates to chimeric fatty body-GRF analogs with increased biological potency, their application as anabolic agents and in the diagnosis and treatment of growth hormone deficiencies. The chimeric fatty body-GRF analogs include an hydrophobic moiety (tail), and can be prepared, either by anchoring at least one hydrophobic tail to the GRF, in the chemical synthesis of GRF. The GRF analogs of the present invention are biodegradable, non-immunogenic and exhibit an improved anabolic potency with a reduced dosage and prolonged activity. |
Inventor(s): | Brazeau; Paul (Montreal, CA), Gravel; Denis (St-Lambert, CA) |
Assignee: | Theratechnologies, Inc. (Montreal, CA) |
Application Number: | 09/148,982 |
Patent Claim Types: see list of patent claims | Compound; Composition; Formulation; Use; |
Drugs Protected by US Patent 6,020,311
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,020,311
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 204881 | ⤷ Try a Trial | |||
Austria | 311453 | ⤷ Try a Trial | |||
Australia | 5500799 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |